Brady (BRC) is back in focus after its Q3 2026 results combined higher sales and earnings with a small trim to full year EPS guidance, sharpening attention on revenue quality.

Brady's recent Q3 2026 result comes after a strong run in the stock, with a 90 day share price return of 15.13% and a 1 year total shareholder return of 35.23%. Longer term total shareholder returns over 3 and 5 years remain similarly strong, suggesting momentum has been building rather than fading into the latest guidance update at a current share price of $94.50.

If you are looking beyond Brady for other ideas, this is a good moment to broaden your search with 18 top founder-led companies

After Brady's strong run and upgraded revenue outlook but slightly softer EPS guidance, the real tension is clear: lean in at $94.50 after this move, or wait for a better entry as execution risks play out in the valuation.

Most Popular Narrative: 6.9% Undervalued

The most followed Brady narrative anchors fair value at $101.50, a touch above the current $94.50 price, putting the focus on what is driving that gap.

The company's deepening product ecosystem and recent acquisitions (Gravotech, Funai Microfluidics, Mecco) expand capabilities in direct part marking, barcode/RFID solutions, and software integration, directly addressing rising global requirements for traceability, regulatory compliance, and asset tracking; this supports entry into higher growth, higher margin markets and drives recurring revenue streams.

Want to see why this Brady narrative leans on faster revenue growth, steadier margins, and a lower future earnings multiple than many expect? The full breakdown spells out how those moving parts feed into the $101.50 fair value anchor and what assumptions have to hold for that gap to close.

Result: Fair Value of $101.50 (UNDERVALUED)

However, the Brady narrative also leans on assumptions that could be tested if organic growth in regions like Europe and Australia remains weak, or if trade tariffs further pressure margins.

Next Steps

If this Brady story seems optimistic, quickly review the underlying data and test the assumptions yourself with 3 key rewards.

Looking for more investment ideas beyond Brady?

If you stop with Brady, you might miss stocks that better match your goals, so use the Simply Wall Street Screener to pressure test fresh opportunities.

• Spot potential upside in quality companies trading below their estimates by scanning 50 high quality undervalued stocks that already clear fundamental checks.
• Build a more resilient core by focusing on income and stability with 9 dividend fortresses that aim to balance yield with staying power.
• Reduce portfolio stress by filtering for 79 resilient stocks with low risk scores that score well on balance sheet strength and risk metrics before headlines move the crowd.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.